Sindusfarma´s Board 2022-2024
Omilton Visconde Jr.
Graduated in Business Administration from Brazilian University PUC-SP (Pontifícia Universidade Católica de São Paulo), with an MBA from the University of Pennsylvania, he is Cellera Farma’s CEO. He was a founding partner of Brazilian company Biosintética Farmacêutica in 1984 and a managing partner of Brazilian company PrevSaúde. He founded the Brazilian company Segmenta Farmacêutica in 2007. He was a chairperson at the pharmaceutical industry association Sindusfarma in four previous terms. He has also chaired the former Febrafarma (Brazilian Federation of Pharmaceutical Industries) and was a member of the Brazilian Council for Economic and Social Development between 2002 and 2008.
An MBA course holder, he is the CEO of Bristol Myers Squibb (BMS) in Brazil. His career in strategic positions in large pharmaceutical industries began in 1999 when he was Eli Lilly’s CEO in Canada. In 2006 he took charge of the company’s Brazilian unit. His professional career in the country also includes being (American multinational medical devices and health care company) Abbott Laboratories’s CEO and prominent positions in important business entities and the pharmaceutical sector.
Cleiton de Castro Marques
Economist. At the age of 13 he started working alongside his father at the Brazilian company Laboratório Prata Ltda., which he transformed in 1978, together with his brothers, into the company União Química Farmacêutica Nacional S/A., specializing in hospital products. In 1997 he founded Biolab Sanus Farmacêutica, focused on medical prescription products, one of the Brazilian companies that invest the most in research, development and innovation in the pharmaceutical sector, with more than 400 patents deposited. In 2011, he bought Laboratório Zurita (today Avert Laboratórios), thus entering the over-the-counter market.
CEO and main shareholder of the Eurofarma Group, one of the largest Brazilian pharmaceutical laboratories, founded by his father, Galliano Billi, in 1972. With over 35 years of experience in the pharmaceutical industry, he began his professional activities in the operations area in the 1980s and 1990s, going through different areas of the company.
Lawyer. He has worked in large pharmaceutical laboratories (such as Novartis and Eurofarma) and Brazilian business entities in the industry (Febrafarma, Interfarma, Abimip etc.). He has been the main executive at Sindusfarma since 2009. Member of several business and government councils including the Industrial Policy Council of the Brazilian Confederation of Industries (CNI), the Brazilian Health Council (CNS) and the Brazilian Commission for the Incorporation of Technology (Conitec) at SUS (Brazilian government Unified Health System).
President: Omilton Visconde Jr. (Cellera Farma)
1st Vice-president: Gaetano Crupi (Bristol-Myers Squibb)
2nd Vice-president: Cleiton de Castro Marques (Biolab)
3rd Vice-president: Maurizio Billi (Eurofarma)
Marcus Sanchez (E.M.S)
Marta Díez (Pfizer)
Tatiana Marante (Biogen)
Roy Benchimol (Janssen)
Breno Oliveira (Hypera)
Hugo Nisenbom (MSD)
Vânia Alcantara Machado (Aché)
Renato Carvalho (Novartis)
1º Adib Jacob (Bayer)
2º Hernâni Sério (Fresenius Kabi)
3º Isabella Wanderley (Novo Nordisk)
4º Ricardo Pacheco (Cristália)
5º Fernando Itzaina (Farmoquímica)
6º Renata Spallici (Apsen)
7º Karla Alcázar (Lilly)
8º Karla Marques (Cimed)
9º Amanda Spina (Janssen)
10º Maria Heloísa Simão (Blanver)
11º Patrick Eckert (Roche)
12º Guilherme Maradei (Natulab)
1º Odilon Costa (Cristália)
2º Rubens Gimenes Filho (Almeida Prado)
3º Walker M. Lahmann (Supera)
1º Luiz Carlos Borgonovi (Nova Química)
2º Magda Giudicissi (Cazi Química)
3º Fernando Salles A. Marques (Arese)
Representative Delegates at Fiesp:
1º Nelson Mussolini
2º Bruno Abreu
1º Arnaldo Pedace
2º Rosana Mastellaro